Case Study
08
Phase II arthritis drug – U.S. and Europe
Challenge
Launch the project at an investigator meeting in Europe ten days after contract signing. Complete as many randomizations as possible in this 140-subject study with extremely narrow inclusion criteria by using only “known” patients within the sites’ databases or that of their referring physicians.
Solution
ThreeWire implemented chart reviews at selected sites in eastern and western Europe, U.K., Canada and the U.S. Candidates identified were contacted either via telephone or letter and offered the opportunity to screen for the study.
Results
Thousands of patient charts were reviewed to identify over 300 potential participants. Approximately 180 were evaluated for suitability for site screening, resulting in 50 site screening visits and 35 randomizations. Project completed in 90 days.
Contact us to see how chart reviews might benefit your enrollment.
